Stephens Investment Management Group LLC Halozyme Therapeutics, Inc. Transaction History

Stephens Investment Management Group LLC

$7.17 Billion
Q4 2024

A detailed history of Stephens Investment Management Group LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Stephens Investment Management Group LLC holds 1,346,957 shares of HALO stock, worth $75.8 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

1,346,957

Previous 1,359,730 0.94%

Holding current value

$75.8 Million

Previous $77.8 Million 17.22%

% of portfolio

0.9%

Previous 1.1%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	SELL	$42.57 - $61.09 $543,746 - $780,302	-12,773 Reduced 0.94%	1,346,957 $64.4 Million
Q3 2024 Oct 28, 2024	SELL	$51.3 - $64.42 $3.19 Million - $4.01 Million	-62,174 Reduced 4.37%	1,359,730 $77.8 Million
Q2 2024 Aug 06, 2024	SELL	$37.81 - $52.4 $4.72 Million - $6.54 Million	-124,762 Reduced 8.07%	1,421,904 $74.5 Million
Q1 2024 May 14, 2024	BUY	$33.68 - $41.95 $950,146 - $1.18 Million	28,211 Added 1.86%	1,546,666 $62.9 Million
Q4 2023 Feb 13, 2024	BUY	$33.32 - $42.1 $2.12 Million - $2.68 Million	63,748 Added 4.38%	1,518,455 $56.1 Million
Q3 2023 Nov 14, 2023	BUY	$36.46 - $44.03 $4.21 Million - $5.09 Million	115,585 Added 8.63%	1,454,707 $55.6 Million
Q2 2023 Aug 14, 2023	BUY	$30.28 - $38.74 $973,562 - $1.25 Million	32,152 Added 2.46%	1,339,122 $48.3 Million
Q1 2023 May 15, 2023	BUY	$32.86 - $55.7 $425,372 - $721,036	12,945 Added 1.0%	1,306,970 $49.9 Million
Q4 2022 Jan 26, 2023	SELL	$40.06 - $59.44 $196,654 - $291,790	-4,909 Reduced 0.38%	1,294,025 $73.7 Million
Q3 2022 Nov 07, 2022	SELL	$38.53 - $51.78 $194,537 - $261,437	-5,049 Reduced 0.39%	1,298,934 $51.4 Million
Q2 2022 Aug 03, 2022	BUY	$37.35 - $48.3 $337,868 - $436,921	9,046 Added 0.7%	1,303,983 $57.4 Million
Q1 2022 May 04, 2022	BUY	$31.97 - $41.06 $647,648 - $831,793	20,258 Added 1.59%	1,294,937 $51.6 Million
Q4 2021 Feb 15, 2022	BUY	$31.82 - $40.75 $133,612 - $171,109	4,199 Added 0.33%	1,274,679 $51.3 Million
Q3 2021 Oct 27, 2021	BUY	$38.47 - $46.42 $6.64 Million - $8.02 Million	172,726 Added 15.73%	1,270,480 $51.7 Million
Q2 2021 Aug 09, 2021	BUY	$38.84 - $51.31 $163,749 - $216,322	4,216 Added 0.39%	1,097,754 $49.8 Million
Q1 2021 May 14, 2021	BUY	$39.51 - $51.45 $4.71 Million - $6.14 Million	119,331 Added 12.25%	1,093,538 $45.6 Million
Q4 2020 Feb 10, 2021	BUY	$25.81 - $43.62 $18.2 Million - $30.8 Million	705,309 Added 262.3%	974,207 $41.6 Million
Q3 2020 Nov 13, 2020	BUY	$25.74 - $29.63 $2.44 Million - $2.8 Million	94,623 Added 54.3%	268,898 $7.07 Million
Q2 2020 Aug 24, 2020	BUY	$16.25 - $26.81 $2.83 Million - $4.67 Million	174,275 New	174,275 $4.67 Million

Others Institutions Holding HALO

# of Institutions

538

Shares Held

123M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.84B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Investment Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stephens Investment Management Group LLC with notifications on news.

Account

Stephens Investment Management Group LLC Halozyme Therapeutics, Inc. Transaction History